炎症性腸疾患における妊娠の管理に関するグローバルコンセンサス声明
Uma Mahadevan1, Cynthia H Seow2, Edward L Barnes3
1Division of Gastroenterology, Department of Medicine, University of California, San Francisco, California.
Inflammatory bowel diseases
|August 28, 2025
まとめ
この世界的なコンセンサスは,妊婦の炎症性腸疾患 (IBD) の管理のためのデータ主導のガイドラインを提供し,専門家の勧告を通じて母と乳児の健康状態を改善することを目的としています.
科学分野:
- 胃腸内科
- 産婦人科
- 公衆衛生
背景:
- 炎症性腸疾患 (IBD) の女性における妊娠は,重大なリスクをもたらす.
- 妊娠中のIBDに関する高品質な研究と薬のデータが限られている.
- 医療従事者の知識とガイドラインの多様性は 患者のケアに不一致をもたらします
研究 の 目的:
- 妊娠中のIBDの管理のための世界的なベストプラクティスを確立する.
- 妊娠中のIBD患者の医療における知識の欠陥や不一致を解決する.
- IBDの妊婦の妊娠率,服薬の順守,治療結果を改善する.
主な方法:
- GRADE (Grading of Recommendations Assessment, Development, and Evaluation) プロセスを利用し,データに基づいた推奨を行いました.
- データが限られている場合,専門家のコンセンサスのためにRAND (研究開発) プロセスを採用した.
- 乳児の健康の基盤として 母親の健康を優先する
主要な成果:
- 34のGRADE勧告と35のコンセンサス声明を策定した.
- 妊娠中のIBDに関連する10の異なるカテゴリーをカバーしました.
- 合成されたデータと専門家の意見は,実践的な指針を形成します.
結論:
- このコンソーシアムは,IBDの妊婦の世話を対象に,データに基づいた実用的なガイドラインを提供することを目的としています.
- 推奨事項は,利用可能な最良の科学研究に基づいています.
- 目標は,世界中のIBDの妊婦の管理と結果を向上させることです.
関連する概念動画
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
413
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
413
01:29Inflammatory Bowel Disease IV: Pharmacological Management
185
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
185
01:21Inflammatory Bowel Disease V: Surgical Management
206
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
206
01:30Inflammatory Bowel Disease II: Crohn's Disease
375
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
375
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
316
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
316
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
201
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
201